TY - JOUR
T1 - Awareness and knowledge of breast cancer rehabilitation among Saudi Arabia physical therapists
AU - Kamal Abdelbasset, Walid
AU - Ibrahim, A. A.
AU - Alsubaie, S. F.
AU - Alrawaili, S. M.
AU - Althomali, O. W.
AU - Hussein, H. M.
AU - Adam Sulieman, Abdelmoneim
AU - Kanwal, R.
N1 - Publisher Copyright:
© 2023 Verduci Editore s.r.l. All rights reserved.
PY - 2023/6
Y1 - 2023/6
N2 - OBJECTIVE: This study aimed to evaluate the physical therapists’ knowledge and awareness of breast cancer, treatment modalities, contraindications, and clinical guidelines. SUBJECTS AND METHODS: A cross-sectional survey was conducted from December 2020 to May 2021 in Saudi Arabia. The sample size was determined using the Raosoft sample size calculator, which indicated the need for 67 participants. All physical therapists of both sex in private and public hospitals in Ha’il and non-Ha’il regions were included in the study. Data was collected by a structured Google form questionnaire, consisting of 4 main domains with a maximum score of 43. RESULTS: 57 physical therapists participated in the current study, out of which 31 were from the Ha’il region (42.1% male, 57.9% female) with a mean age of 29±7 years and a mean experience 6±7years. The referral of breast cancer patients was only 22.8%. Interestingly only 22.8% of the hospital has specific setups for oncology rehabilitation, and 12.3% have reported positive about continuing professional development (CPDs) workshops for breast cancer organized by their hospitals. 5.3% of patients with breast cancer are aware of the benefit of oncology rehabilitation, while 22.8% of patients come for follow-up sessions in the rehabilitation department. According to multiple regression, only gender was statistically significant for prediction, p<0.05. Females increased the mean score by 5.996 more than males. Female therapists are 38.2% more aware than males. CONCLUSIONS: Although physical therapists have a low level of knowledge and an average level of awareness, with a higher number of women than men, attitudes toward physical therapy are quite high, and the profession is practiced exceptionally well.
AB - OBJECTIVE: This study aimed to evaluate the physical therapists’ knowledge and awareness of breast cancer, treatment modalities, contraindications, and clinical guidelines. SUBJECTS AND METHODS: A cross-sectional survey was conducted from December 2020 to May 2021 in Saudi Arabia. The sample size was determined using the Raosoft sample size calculator, which indicated the need for 67 participants. All physical therapists of both sex in private and public hospitals in Ha’il and non-Ha’il regions were included in the study. Data was collected by a structured Google form questionnaire, consisting of 4 main domains with a maximum score of 43. RESULTS: 57 physical therapists participated in the current study, out of which 31 were from the Ha’il region (42.1% male, 57.9% female) with a mean age of 29±7 years and a mean experience 6±7years. The referral of breast cancer patients was only 22.8%. Interestingly only 22.8% of the hospital has specific setups for oncology rehabilitation, and 12.3% have reported positive about continuing professional development (CPDs) workshops for breast cancer organized by their hospitals. 5.3% of patients with breast cancer are aware of the benefit of oncology rehabilitation, while 22.8% of patients come for follow-up sessions in the rehabilitation department. According to multiple regression, only gender was statistically significant for prediction, p<0.05. Females increased the mean score by 5.996 more than males. Female therapists are 38.2% more aware than males. CONCLUSIONS: Although physical therapists have a low level of knowledge and an average level of awareness, with a higher number of women than men, attitudes toward physical therapy are quite high, and the profession is practiced exceptionally well.
KW - Awareness
KW - Breast cancer
KW - Knowledge
KW - Physical therapists
UR - http://www.scopus.com/inward/record.url?scp=85163937602&partnerID=8YFLogxK
U2 - 10.26355/eurrev_202306_32771
DO - 10.26355/eurrev_202306_32771
M3 - Article
C2 - 37401271
AN - SCOPUS:85163937602
SN - 1128-3602
VL - 27
SP - 5370
EP - 5377
JO - European Review for Medical and Pharmacological Sciences
JF - European Review for Medical and Pharmacological Sciences
IS - 12
ER -